Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...

Researchers discovered a promising leukemia drug breakthrough that could help patients overcome treatment resistance, ...

Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show that cancer drug treatments can be safely and effectively personalized based ...

Pharmaceuticals giant, Merck & Co. Inc. (NYSE: MRK), is reportedly in talks to acquire cancer drug-maker Revolution Medicines ...

The startup is developing a medicine that can very specifically degrade cancerous forms of EGFR, the target of several ...

Amgen Inc. has acquired cancer drug developer Dark Blue Therapeutics Ltd. in a deal worth as much as $840 million, expanding ...

Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and ...

Smart pill bottles may boost adherence to oral breast cancer therapies through daily reminders and tracking, though cost and ...

A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-estrogen ...

The FDA and European Medicines Agency (EMA) have awarded orphan drug designation to CPI-008 (cRGD-ZW800-1), a novel ...

Common diabetes drugs may do more than regulate blood sugar—they could also influence how cancers grow, spread, or slow down.

Grieving mothers watched from the Senate Galley as the bipartisan bill to incentivize new drug discoveries was denied passage ...